India Reddys Laboratories Tender

Dr. Reddys Laboratories Ltd. announced the launch of Doxercalciferol Injection 4 mcg2 mL 2 mcgmL Multiple-Dose Vials the therapeutic generic equivalent of Hectorol doxercalciferol Injection 4 mcg2 mL 2 mcgmL MultipleDose Vials approved by the U.S. Food and Drug Administration USFDA.The Hectorol Injection 4 mcg2 mL 2 mcgmL Single-Dose Vials and Multiple-Dose Vials brand and generics had U.S. sales of approximately 138 million MAT for the most recent twelve months ending in September 2019 according to IQVIA Health.Hectorol is a trademark of Sanofi-Aventis US LLC.